Home
The Latest Stories
NEW YORK (Reuters Health) - Nearly 30 percent of U.S. diabetics over the age of 40 may have a diabetes-related eye disorder, with 4 percent of this population affected severely enough that their vision is threatened, suggests a new study. The condition, known as diabetic retinopathy, involves damage to the eye's retina and is the leading cause of new ...
AstraZeneca PLC says it has paid around $198 million to settle U.S. lawsuits over its antipsychotic drug Seroquel. AstraZeneca said Monday it has paid out to around 17,500 claimants regarding allegations the drug causes diabetes in some users. The company says the payouts won't affects its ...
NEW YORK (Reuters Health) - Pregnant women with a history of pregnancy-related diabetes, also called gestational diabetes, have a good chance of developing the condition again, suggests a large new study. Researchers found that the risk of having gestational diabetes during a future pregnancy increases with each previously affected one -- from 41 percent after the first to 57 percent after two ...
NEW YORK (Reuters Health) - Middle-aged adults born at the height of China's famine in the 1950s and 60s may have a greater risk of abnormally high blood sugar than those born just a few years earlier or later, a new study finds. The findings, reported in the journal Diabetes, support the theory that nutrition and growth during fetal development ...
CHICAGO (Reuters) - A new understanding of the link between diabetes and obesity may help drug companies design safer versions of treatments like GlaxoSmithKline's Avandia, U.S. researchers said on Wednesday. The researchers had believed Avandia and Takeda Pharmaceutical Co's Actos work by stimulating a protein known as PPAR-gamma. Now the team thinks the drugs also act on the ...
Federal health officials say new patients should not be enrolled in a study of GlaxoSmithKline's controversial diabetes pill Avandia, after experts last week said the drug increases heart risks. The Food and Drug Administration issued a hold on the study to update researchers ...
Drugmaker Bristol-Myers Squibb Co. is expected to focus on a raft of recent positive research data and plans to seek approval for several drugs when it reports its second-quarter results before the stock market opens Thursday. WHAT TO WATCH FOR: Analysts anticipate detailed updates on several key ...
CHICAGO (Reuters) - The U.S. Food and Drug Administration has warned Abbott Laboratories' diabetes care unit about manufacturing problems at its Alameda, California plant, a letter released Tuesday said. In a letter dated July 2, FDA said its inspectors found Abbott's Freestyle and Navigator blood glucose monitoring products were adulterated and not conforming with codes for good quality system ...
The following recalls have been announced: _ Good Health Inc., of Canutillo, Texas, is recalling select lots of the dietary supplement Vialipro because they could contain a compound that is chemically similar to the erectile dysfunction drug sildenafil. This compound could interact with nitrates found in some prescription drugs for diabetes, high blood pressure, high cholesterol ...
A majority of members of a key advisory committee recommended that the US government allow diabetes drug Avandia to stay on the market with greater restrictions on its sale. Most of the panel's members agreed that the drug increases the risk of heart problems, but only 12 of the 33-member expert panel voted to remove GlaxoSmithKline's one-time blockbuster ...
